These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33378666)

  • 21. The 3.2-Å resolution structure of human mTORC2.
    Scaiola A; Mangia F; Imseng S; Boehringer D; Berneiser K; Shimobayashi M; Stuttfeld E; Hall MN; Ban N; Maier T
    Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33158864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.
    Beck C; Rodriguez-Vargas JM; Boehler C; Robert I; Heyer V; Hanini N; Gauthier LR; Tissier A; Schreiber V; Elofsson M; Reina San Martin B; Dantzer F
    Cell Death Differ; 2019 Sep; 26(9):1615-1630. PubMed ID: 30442946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteome and Phosphoproteome Analysis of Brown Adipocytes Reveals That RICTOR Loss Dampens Global Insulin/AKT Signaling.
    Entwisle SW; Martinez Calejman C; Valente AS; Lawrence RT; Hung CM; Guertin DA; Villén J
    Mol Cell Proteomics; 2020 Jul; 19(7):1104-1119. PubMed ID: 32234964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma.
    Akgül S; Li Y; Zheng S; Kool M; Treisman DM; Li C; Wang Y; Gröbner S; Ikenoue T; Shen Y; Camelo-Piragua S; Tomasek G; Stark S; Guduguntla V; Gusella JF; Guan KL; Pfister SM; Verhaak RGW; Zhu Y
    Cell Rep; 2018 Jul; 24(2):463-478.e5. PubMed ID: 29996106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing Acsl4 in absence of mTORC2/Rictor drove β-cell dedifferentiation via inhibiting FoxO1 and promoting ROS production.
    Cui C; Li T; Xie Y; Yang J; Fu C; Qiu Y; Shen L; Ni Q; Wang Q; Nie A; Ning G; Wang W; Gu Y
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166261. PubMed ID: 34455055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UBXN2A, a Ubiquitin-Like Protein, Alters Proteins in mTORC2 Pathway.
    Reihe C
    S D Med; 2022 Oct; 75(10):456-458. PubMed ID: 36889268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
    Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
    Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammalian target of rapamycin complex 2 regulates muscle glucose uptake during exercise in mice.
    Kleinert M; Parker BL; Fritzen AM; Knudsen JR; Jensen TE; Kjøbsted R; Sylow L; Ruegg M; James DE; Richter EA
    J Physiol; 2017 Jul; 595(14):4845-4855. PubMed ID: 28464351
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Kim LC; Rhee CH; Chen J
    Mol Cancer Res; 2020 Nov; 18(11):1675-1684. PubMed ID: 32801163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2.
    Guo Z; Zhang X; Zhu H; Zhong N; Luo X; Zhang Y; Tu F; Zhong J; Wang X; He J; Huang L
    Oncol Rep; 2021 Feb; 45(2):523-534. PubMed ID: 33416177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rictor, an essential component of mTOR complex 2, undergoes caspase-mediated cleavage during apoptosis induced by multiple stimuli.
    Zhao L; Zhu L; Oh YT; Qian G; Chen Z; Sun SY
    Apoptosis; 2021 Jun; 26(5-6):338-347. PubMed ID: 33905036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of Rictor/mTORC2 signaling acts as a pivotal strategy to protect against sensorineural hearing loss.
    Fu X; Li P; Zhang L; Song Y; An Y; Zhang A; Liu W; Ye C; Zhang Y; Yue R; Sun X; Chai R; Wang H; Gao J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2107357119. PubMed ID: 35238644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.
    Manning JR; Thapa D; Zhang M; Stoner MW; Traba J; Corey C; Shiva S; Sack MN; Scott I
    Biochem J; 2019 Jun; 476(12):1713-1724. PubMed ID: 31138772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.
    Xu M; Wang H; Wang J; Burhan D; Shang R; Wang P; Zhou Y; Li R; Liang B; Evert K; Utpatel K; Xu Z; Song X; Che L; Calvisi DF; Wang B; Chen X; Zeng Y; Chen X
    Am J Pathol; 2020 Apr; 190(4):817-829. PubMed ID: 32035060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When mTORC2-AKT signaling meets cell polarity.
    Daulat AM; Borg JP
    Cell Cycle; 2016 Nov; 15(22):3003-3004. PubMed ID: 27462958
    [No Abstract]   [Full Text] [Related]  

  • 36. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
    Yoon MS
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous nuclear ribonucleoprotein M associates with mTORC2 and regulates muscle differentiation.
    Chen WY; Lin CL; Chuang JH; Chiu FY; Sun YY; Liang MC; Lin Y
    Sci Rep; 2017 Jan; 7():41159. PubMed ID: 28106162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
    Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
    J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis.
    Ignacio A; Cipelli M; Takiishi T; Favero Aguiar C; Fernandes Terra F; Ghirotto B; Martins Silva E; Castoldi A; Magalhães YT; Antonio T; Nunes Padovani B; Ioshie Hiyane M; Andrade-Oliveira V; Forti FL; Olsen Saraiva Camara N
    J Leukoc Biol; 2024 Oct; 116(4):779-792. PubMed ID: 38652699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTOR hyperactivity and
    Sztankovics D; Moldvai D; Petővári G; Dankó T; Szalai F; Miyaura R; Varga V; Nagy N; Papp G; Pápay J; Krencz I; Sebestyén A
    Pathol Oncol Res; 2024; 30():1611643. PubMed ID: 38515456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.